Cesca Therapeutics Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
17,963.00
15,987.00
16,042.00
11,929.00
14,525.00
9,672
Cost of Goods Sold (COGS) incl. D&A
11,434.00
10,101.00
11,293.00
9,185.00
8,686.00
7,479
Gross Income
6,529.00
5,886.00
4,749.00
2,744.00
5,839.00
2,193
SG&A Expense
10,921.00
13,211.00
19,608.00
13,609.00
15,079.00
12,361
EBIT
4,392.00
7,325.00
14,859.00
10,865.00
9,240.00
10,168
Unusual Expense
834.00
1,715.00
117.00
312.00
60.00
32,781
Non Operating Income/Expense
2,140.00
-
124.00
44.00
51.00
24
Interest Expense
-
-
-
7,991.00
20,519.00
2,697
Pretax Income
3,086.00
9,034.00
14,852.00
18,588.00
29,768.00
45,670
Income Tax
-
403.00
-
-
673.00
4,730
Consolidated Net Income
3,086.00
8,631.00
14,852.00
18,588.00
29,095.00
40,940
Net Income
3,086.00
8,631.00
14,852.00
18,588.00
29,095.00
39,716
Net Income After Extraordinaries
3,086.00
8,631.00
14,852.00
18,588.00
29,095.00
39,716
Net Income Available to Common
3,086.00
8,631.00
14,852.00
18,588.00
29,095.00
39,716
EPS (Basic)
3.80
7.12
7.36
7.57
3.27
21.57
Basic Shares Outstanding
826.30
1,211.70
2,017.60
2,455.50
8,904.50
1,841.30
EPS (Diluted)
3.73
7.12
7.36
7.57
3.27
21.57
Diluted Shares Outstanding
826.30
1,211.70
2,017.60
2,455.50
8,904.50
1,841.30
EBITDA
3,854.00
6,332.00
13,508.00
9,697.00
8,473.00
9,498
Non-Operating Interest Income
-
6.00
-
-
-
-
About Cesca Therapeutics
View Profile
